GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Polaris Group (TPE:6550) » Definitions » Price-to-Free-Cash-Flow

Polaris Group (TPE:6550) Price-to-Free-Cash-Flow : N/A (As of May. 28, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Polaris Group Price-to-Free-Cash-Flow?

As of today (2025-05-28), Polaris Group's share price is NT$40.00. Polaris Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-4.93. Hence, Polaris Group's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Polaris Group's Price-to-Free-Cash-Flow or its related term are showing as below:

TPE:6550's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.22
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Polaris Group's Free Cash Flow per Share for the three months ended in Mar. 2025 was NT$-1.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was NT$-4.93.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -65.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -19.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 13.60% per year.

During the past 11 years, Polaris Group's highest 3-Year average Free Cash Flow per Share Growth Rate was 36.90% per year. The lowest was -65.30% per year. And the median was 23.80% per year.


Polaris Group Price-to-Free-Cash-Flow Historical Data

The historical data trend for Polaris Group's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris Group Price-to-Free-Cash-Flow Chart

Polaris Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Polaris Group Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Polaris Group's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Polaris Group's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polaris Group's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polaris Group's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Polaris Group's Price-to-Free-Cash-Flow falls into.


;
;

Polaris Group Price-to-Free-Cash-Flow Calculation

Polaris Group's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=40.00/-4.932
=N/A

Polaris Group's Share Price of today is NT$40.00.
Polaris Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-4.93.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Polaris Group  (TPE:6550) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Polaris Group Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Polaris Group's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Polaris Group Business Description

Traded in Other Exchanges
N/A
Address
NO.298, Ruiguang Road, 7th floor, Neihu District, Taipei, TWN
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.

Polaris Group Headlines

No Headlines